These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
17 results:

  • 1. The role of surgical intervention in primary colorectal lymphoma: A SEER population-based analysis.
    Cai YB; Chen HY; He JJ; Hu YT; Yang Q; Chen LB; Xiao Q; Ding KF
    Oncotarget; 2016 Nov; 7(44):72263-72275. PubMed ID: 27708217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A taspine derivative supresses Caco-2 cell growth by competitively targeting EphrinB2 and regulating its pathway.
    Dai B; Wang W; Ma Y; Liu R; Zhang Y
    Oncol Rep; 2016 Sep; 36(3):1526-34. PubMed ID: 27460008
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer.
    Sun Z; Ou C; Ren W; Xie X; Li X; Li G
    Oncotarget; 2016 Jul; 7(30):47536-47555. PubMed ID: 27286457
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MTA1 Is Up-regulated in colorectal cancer and Is Inversely Correlated with Lymphatic Metastasis.
    Li J; Ye L; Sun PH; Satherley L; Hargest R; Zhang Z; Jiang WG
    Cancer Genomics Proteomics; 2015; 12(6):339-45. PubMed ID: 26543080
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
    Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
    Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
    Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
    Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
    Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
    Li X; Liu B; Xiao J; Yuan Y; Ma J; Zhang Y
    J Gastrointest Surg; 2011 Nov; 15(11):2001-10. PubMed ID: 21786062
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab.
    Moehler M; Frings C; Mueller A; Gockel I; Schimanski CC; Biesterfeld S; Galle PR; Holtmann MH
    World J Gastroenterol; 2008 Jul; 14(26):4156-67. PubMed ID: 18636661
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Relationship of vascular endothelial growth factor-C and lymphangiogenesis with the development and prognosis of colon cancer].
    Jiang JB; Li XM; Zhang WD; Zhu M; Shou NH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):516-9. PubMed ID: 16299655
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Correlation of lymphangiogenesis to progression of colorectal cancer].
    Wang TB; Huang YH; Lan P; Song XM; Wang JP
    Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma.
    Onogawa S; Kitadai Y; Tanaka S; Kuwai T; Kimura S; Chayama K
    Cancer Sci; 2004 Jan; 95(1):32-9. PubMed ID: 14720324
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
    Parr C; Jiang WG
    Int J Oncol; 2003 Aug; 23(2):533-9. PubMed ID: 12851706
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary colonic lymphoma.
    Doolabh N; Anthony T; Simmang C; Bieligk S; Lee E; Huber P; Hughes R; Turnage R
    J Surg Oncol; 2000 Aug; 74(4):257-62. PubMed ID: 10962456
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa.
    André T; Kotelevets L; Vaillant JC; Coudray AM; Weber L; Prévot S; Parc R; Gespach C; Chastre E
    Int J Cancer; 2000 Apr; 86(2):174-81. PubMed ID: 10738243
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.